Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup

While Roche $RHHBY posted its Q3 update on the numbers, highlighting the importance of its new blockbusters in replacing some aging franchises, the R&D group used the occasion to unceremoniously sweep out a roster of losers from the pipeline.